Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DTNA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IRGQ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PNPLA8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRMT7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LYPLA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLX1B-SULT1A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TINF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA1468 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMNB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARFRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R3D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC29A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF114 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SH3GL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC35B4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCTD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on